Abstract Tick-borne encephalitis virus (TBEV) is a zoonotic agent that causes fatal encephalitis in humans. 2'-5'-oligoadenylate synthetase 1b (Oas1b) has been identified as a flavivirus resistance gene, but most inbred laboratory mice do not possess a functional Oas1b gene. In this study, a congenic strain carrying a functional Oas1b gene, B6.MSM-Oas, was used to evaluate the pathogenicity of Far-Eastern TBEV. Although intracerebral infection of B6.MSM-Oas mice by Oshima 5-10 resulted in limited signs of illness, infection by Sofjin-HO resulted in death with severe neurologic signs. While Oshima 5-10 was cleared from the brain, Sofjin-HO was not cleared despite a similar level of expression of the intact Oas1b gene. Necrotic neurons with viral antigens and inflammatory reactions were observed in the brain infected with Sofjin-HO. These data indicate that the different susceptibility to the antiviral activity of Oas1b resulted in a difference in neurovirulence in the two TBEV strains.
Introduction
Tick-borne encephalitis virus (TBEV) is a member of the genus Flavivirus within the family Flaviviridae. Tickborne encephalitis (TBE) is endemic in Europe, Russia, and Far-East Asia, including Japan, and about 10,000 cases of the disease are reported every year on the Eurasian continent [28] . TBEV has been subdivided into three subtypes: the Far-Eastern subtype, which causes Russian spring-summer encephalitis in Russia; the western European subtype; and the Siberian subtype [5, 9] . Infection with the Far-Eastern subtype of the virus causes severe encephalitis; case fatality rates are reported to be 20-60 %. Thus, TBE is a significant public-health problem in these endemic regions.
Our previous studies showed that the Far-Eastern subtype of the TBEV Oshima strain, which was isolated in Japan [30] , caused different disease of the central nervous system (CNS) when compared with the prototype strain Sofjin-HO [3, 10] . In addition to the development of CNS disease, some host responses (which were not observed after infection of Sofjin-HO) were shown to be involved in the induction of a fatal infection. However, the detailed mechanisms remain largely unknown. Since the amino acid sequence identity between the two strains is more than 98 % [7] , comparative analysis can reveal important information regarding the pathogenicity of TBEV.
Interferon-inducible 2'-5'-oligoadenylate synthetases (OASs) play important roles in the antiviral activity against RNA virus infections. After activation by double-stranded RNA, OAS proteins polymerize adenosine 5'-triphosphate (ATP) into 2'-5'-linked oligoadenylates (2-5As) [22, 24] . These 2-5As activate RNase L, resulting in the degradation of viral RNA [23] . The OAS family consists of OAS1, OAS2, OAS3, and multiple OAS-like genes in humans [2, 8, 11] , and eight small Oas1 (Oas1a-h), one Oas2, one Oas3, and two Oas-like (OasL1 and OasL2) genes in mice [12] .
The murine isoform Oas1b has been identified as a critical determinant of the genetic susceptibility of mice to infection with West Nile virus (WNV), a mosquito-borne flavivirus [16, 20] . It was recently reported that genetic variation in human OAS is associated with a predisposition to TBEV-and WNV-induced diseases [1, 15] . However, little is known about the detailed mechanism of OASs in the pathogenesis of tick-borne flaviviruses. Since most inbred laboratory mice do not possess a functional Oas1b gene due to a premature stop codon, the susceptibility to flaviviruses is increased. The increased susceptibility has made it difficult to analyze the roles of OASs in flavivirus pathogenesis in detail.
We previously established a congenic strain in which the Oas locus of the Japanese feral-mouse-derived strain MSM/Ms was introduced to the widely used mouse strain C57BL/6J (B6) [18] . These B6.MSM-Oas mice have a functional Oas1b gene and show resistance to infection by WNV but not influenza virus. In this study, B6.MSM-Oas mice were used to evaluate the pathogenesis of the FarEastern subtype of TBEV, and differences in susceptibility of different strains to the antiviral responses of Oas1b were observed.
Materials and methods

Viruses
The Sofjin-HO strain of TBEV (accession no. 062064) was first isolated from the brain of a TBE patient in Khabarovsk in 1937 [4] . The virus (of unknown passage history) was generously supplied by Dr. Ohya (National Institute of Infectious Diseases, Tokyo, Japan) in 1967; the virus was further passaged seven times in suckling mouse brain and twice in baby hamster kidney (BHK) cells. The Oshima 5-10 strain was isolated from dogs in 1995 in Hokuto City, Japan [30] and was passaged twice in suckling mouse brain and once in BHK cells. Viruses were handled in biosafety level 3 containment. BHK cells were grown at 37°C in Eagle's minimum essential medium (MEM) supplemented with 8 % fetal calf serum (FCS) and L-glutamine.
Virus infection in mice
Five-week-old female C57BL/6J (B6) (Charles River Laboratories Japan, Inc., Yokohama, Japan) or C57BL/ 6J.MSM-Oas (B6.MSM-Oas) mice available from Riken BRC (B6.MSM-[D5Mit367-D5Mit242]/Hkv: RBRC. no. RBRC05266) [18] were anesthetized and then inoculated intracerebrally with a range of 10 1 -10 5 plaque-forming units (pfu) of TBEV. The mice were weighed daily and checked for clinical signs for 21 days. Morbidity was defined as the appearance of [10 % weight loss. For analysis of the viral titer and gene expression, three mice were sacrificed on days 3, 6, and 9 post-infection, and brain samples were collected following perfusion with cold PBS and stored at -80°C. All procedures were approved by the President of Hokkaido University after review by the Animal Care and Use Committee of Hokkaido University.
Viral titration
Brain samples were weighed, homogenized, and prepared as 10 % suspensions (w/v) in PBS supplemented with 10 % FCS. The suspensions were clarified by centrifugation (4,000 rpm for 5 min at 4°C), and the viruses in the supernatants were titrated.
Plaque assays were performed with BHK cells using 12-well plates. Serial tenfold dilutions of the organ suspensions were inoculated to the monolayer of cells. After incubation for 1 h at 37°C, 1.5 % carboxymethylcellulose-MEM was added to the cells. The incubation was continued for four days, and the monolayers were stained with 0.1 % crystal violet in 10 % formalin neutral buffer solution. Plaques were counted, and infectivity titers were expressed as pfu/mL. Semi-quantitative RT-PCR Total brain tissue RNA isolated by Isogen (Nippon Gene, Tokyo, Japan) was used for RT-PCR. Equal amounts (0.2 lg) of RNA were subjected to reverse transcription using SuperScript II and Oligo(dT) 20 Primer (Life Technologies, Carlsbad, CA, USA) at 42°C for 50 min and 70°C for 15 min, followed by 26 (b-actin) and 35 (Oas1a and Oas1b) PCR cycles consisting of 94°C for 30 s, 55°C for 30 s and 68°C for 2 min using Platinum Taq (Life Technologies). The following primers were used: b-actin-forward, 5'-CATGAACAACAGGTGGATCCTCC ACGC-3'; b-actin-reverse, 5'-CAGTTTTGGAAGTTTCT GGTAAGTCTTCG-3'; Oas1a-forward, 5'-TGTTAATAC TTCCAGCAAGC-3'; Oas1a-reverse, 5'-GCAAAGACAG TGAGCAACTCT-3'; Oas1b-forward, 5'-AGGCTGCCGC CTGGCTGCAAT-3'; Oas1b-reverse, 5'-TAAGGCAGG AGGATGGCAATA-3'.
Histopathological examination
Mice infected with 10 4 pfu of TBEV were killed at 9 days post-infection, and fixed brain tissues were embedded in paraffin, sectioned and stained with haematoxylin and eosin as described previously [19] . Immunohistochemical detection of TBEV antigens was performed using rabbit polyclonal antibodies against E protein to detect TBEV antigens [31] .
Results
Differential resistance of Oas-congenic mice to the neurovirulence of the TBEV strains Initially, B6.MSM-Oas mice were subcutaneously infected with the Sofjin-HO or Oshima 5-10 strain of TBEV. Following infection with 10 6 pfu of either strain, all mice survived without any clinical signs. No viremia or viral multiplication in organs (spleen, lung, liver, and brain) was observed (data not shown). These data indicate that, in B6.MSM-Oas mice, the virus was eliminated in the early stage of infection following subcutaneous challenge.
To evaluate the neurovirulence of TBEV, B6 and B6.MSM-Oas mice were intracerebrally infected with serial doses of the Sofjin-HO or Oshima 5-10 strain. Although some B6 mice survived at low doses of infection (10 and 100 pfu), most of the mice died following intracerebral infection with either TBEV strain ( Table 1 ). All mice showing signs of illness died within 2 days from the onset of the disease. The mice that survived at a low dose of infection did not show any clinical signs of disease. The 50 % lethal dose (LD 50 ) in B6 mice was 16.2 pfu for Sofjin-HO and 20.9 pfu for Oshima 5-10. In the B6.MSMOas mice infected with the Sofjin-HO strain, some mice showed resistance to viral infection at a low dose (LD 50 = 148 pfu). All mice at 10 pfu of infection and 60 % of the mice at 100 pfu of infection survived without any signs of illness; however, 40 % of the mice at 100 pfu of infection and all mice at more than 1,000 pfu of infection died. In contrast, most of the B6.MSM-Oas mice infected with 1,000 pfu or more of the Oshima 5-10 strain showed general signs of illness, but all of the mice survived. Figure 1 shows survival curves (a) and weight changes (b) following intracerebral infection with 10 4 pfu of TBEV. B6 mice infected with both virus strains and B6.MSM-Oas mice infected with the Sofjin-HO strain remained asymptomatic for 4-6 days and then started to exhibit general signs of illness, including weight loss, a hunched posture, ruffled fur, and general malaise. The mice lost weight rapidly and died within 3-4 days from onset of disease. Most of the mice ([80 % for each group) exhibited neurological signs of paralysis before death. In contrast, the B6.MSM-Oas mice infected with Oshima 5-10 remained asymptomatic for 5-6 days and then started to exhibit general signs of illness, including weight loss, a hunched posture, ruffled fur, and general malaise. However, the weight decrease was very slight compared to the other groups, and all of the mice recovered at 11-14 days postinfection. No neurological signs were observed. These data indicated that in the B6.MSM-Oas mice, neurovirulence was different for the two strains of TBEV.
Viral clearance from Oas-congenic mouse brain
To examine reduction of viral replication caused by the expression of a functional Oas1b gene, viral loads in the brain were investigated after intracerebral infection with 10 4 pfu of TBEV. At 3 days after infection, there were no significant differences in the viral loads between the B6 and B6.MSM-Oas mice and between the Sofjin-HO and Oshima 5-10 strains (Fig. 2) . At 6 days post-infection, a lower titer of virus was observed in the B6.MSM-Oas mice infected with the Oshima 5-10 strain than in the B6 mice, while similarly high levels of virus ([10 7 pfu/mL) were detected in both the B6 and B6.MSM-Oas mice infected with Sofjin-HO. This trend was more apparent at 9 days post-infection. The viral loads in the B6.MSM-Oas mice infected with the Oshima 5-10 strain were drastically reduced, and the virus was cleared from the brain in two of the four mice. However, the viral loads in the B6.MSMOas mice infected with the Sofjin-HO strain remained as high as in the B6 mice.
To examine whether the difference in viral clearance in the B6.MSM-Oas mice between the Sofjin-HO and Oshima 5-10 strains was due to the expression level of Oas1b, the expression of Oas1a and Oas1b was analyzed by semiquantitative RT-PCR. As shown in Fig. 3 , the expression levels of both Oas1a and Oas1b increased from 3 to 6 days post-infection, and there was no difference between infection with Sofjin-HO and Oshima 5-10. Oas1a protein expression was also similar after infection of Sofjin-HO or Oshima 5-10 ( Supplementary Fig. 1 ). These data indicated that both the Sofjin-HO and Oshima 5-10 strains possess a comparable ability to induce Oas1b expression. However, the Oshima 5-10 strain was cleared from the brain as intact Oas1b was expressed, whereas the Sofjin-HO strain was not cleared despite a similar level of expression of intact Oas1b.
Histopathological features of the B6.MSM-Oas mice
The histopathological features of the B6.MSM-Oas mice were examined following intracerebral infection with the (Table 2 and Fig. 4 ). Perivascular cuffing was observed prominently in the brain as an anti-viral response (Fig. 4a-c) , and a number of degenerated Purkinje cells and meningitis were observed in the cerebellum (Fig. 4b) . In contrast, many viral-antigen-positive cells and inflammatory reactions were observed throughout the brain of mice infected with the Sofjin-HO strain (Table 2 and Fig. 4d-f) . Furthermore, necrotic or degenerated neurons with inflammatory cell infiltration were observed in the cerebrum and cerebellum (Fig. 4d and e) .
Compared to the B6 mice infected with Oshima 5-10 or Sofjin-HO (Fig. 5 and Table 2 ), inflammatory infiltrations were slight in B6.MSM-Oas mice infected with Sofjin-HO, but the histopathological signs of neural degeneration and inflammation in Sofjin-HO were similar to those observed in B6 mice infected with either strain. These data suggest that B6.MSM-Oas mice infected with the Sofjin-HO strain died due to acute neurological dysfunction throughout the brain; in contrast, the mice infected with the Oshima 5-10 strain survived because the level of viral replication was reduced by the anti-viral activity of Oas1b.
Discussion
In this study, we demonstrated that B6.MSM-Oas mice, which possess a functional Oas1b gene, showed different responses to two different strains of TBEV. In B6.MSMOas mice infected intracerebrally with the Oshima 5-10 strain, the virus was cleared and Oas1b was expressed. All infected B6.MSM-Oas mice survived, while most of the virus-infected B6 mice died. Dose-dependent morbidity was observed during the viral clearance phase, while the clinical manifestation was transient with general signs of disease, including weight loss, without any neurological signs; these general signs were considered to be associated with the host's anti-viral response, including inflammation, as observed by histopathological analysis. These results are consistent with those of previous studies of flavivirusresistant mice infected intracerebrally with mosquito-borne flaviviruses [26, 27] .
In contrast, the B6.MSM-Oas mice showed no resistance to infection with the Sofjin-HO strain. The infected mice died in a dose-dependent manner, and the fatality rate was 100%. Many mice showed neurological signs, including paralysis, and severe cytopathic effects were observed in the virus-infected neurons with inflammatory responses throughout the brain, as observed in B6 mice. Unlike infection with Oshima 5-10, the viral titer of Sofjin-HO in the B6.MSM-Oas mice was not reduced, similar to the effect in B6 mice, despite expression of the functional Oas1b gene. These data suggest that the anti-flavivirus activity of Oas1b successfully reduced the level of viral replication of the TBEV Oshima 5-10 strain, whereas the Sofjin-HO strain overcame and/or escaped the reduction of The pathogenicity of TBEV in B6.MSM-Oas mice closely resembled that observed in human cases. The Sofjin-HO strain was derived from the brain of a TBE patient [4] and is closely related to another reference strain, Khabarovsk-Obor-4 (accession no. FJ214111), which was also isolated from the brain of a TBE patient with a lethal outcome [13] . The Oshima 5-10 strain was isolated from a sentinel dog in Hokkaido, Japan [30] . Endemic foci of Oshima-related strains have been maintained for more than 10 years in the area [32] , but only one human case of TBE has been reported. Therefore, Japanese TBEV isolates, including the Oshima 5-10 strain, have been considered to be relatively avirulent. A recent phylogenic analysis of the Far-Eastern subtype of TBEV revealed that the Sofjin-HO strain is genetically closely related to strains isolated from TBE patients in Far-Eastern Russia, whereas the Oshima 5-10 strain is more closely related to strains isolated from asymptomatic patients bitten by ticks [14] . Our results concerning the pathological features of intracerebral infection in B6.MSM-Oas mice, which were not identified in B6 mice, agreed with the genetic background of the strains. Peripheral infection in B6.MSM-Oas mice resulted in viral clearance during the initial stage of infection, and the mice showed no signs of disease. This is consistent with previous data for WNV [18] and may be related to the low incidence rate in flavivirus-infected individuals. Our previous data showed that peripheral viral multiplication did not differ between the Sofjin-HO and Oshima 5-10 strains in B6 mice and did not correlate with the progression of disease in TBEV infection [10, 29] . Considering the results of intracerebral infection in B6.MSM-Oas mice, it may be possible to distinguish clinical conditions based on the TBEV strain after viral invasion of the brain.
Oas1b is induced by a STAT2-dependent pathway, and does not possess 2-5A synthetic activity [6, 21] . The flavivirus-specific antiviral action of Oas1b is independent of the 2-5A/RNase L pathway, which is important for broad nonspecific antiviral activity [25] . An alternative mechanism for this flavivirus-specific antiviral action has been suggested, but it is not well understood. The viral factor that is the target of the flavivirus-specific antiviral activity of Oas1b is also unknown. Only one study has reported that mutations in the NS3 helicase (NS3-365) and 2K peptide (2K-9) of WNV promoted resistance to the antiviral action of Oas1b [17] , but no differences exist in these two amino acids between Sofjin-HO and Oshima 5-10. The protein sequence homology between Sofjin-HO and Oshima 5-10 is [98 %, and this difference likely determines the level of susceptibility to the antiviral action of Oas1b. Therefore, the identification of the determinant underlying the differential pathogenicity observed in B6.MSM-Oas mice will help reveal the molecular mechanism of the flavivirusspecific antiviral activity of Oas1b.
In summary, using congenic mice possessing a functional Oas1b gene, we demonstrated that intracerebral infection with TBEV caused clinical conditions associated with human infection and that reduction of viral replication by the flavivirus-specific antiviral activity of Oas1b was different for different TBEV strains. This congenic mouse strain may be a useful model for studying the detailed pathogenicity of tick-borne flaviviruses and the molecular mechanism of the flavivirus-specific antiviral activity of Oas1b, which cannot be analyzed in most inbred laboratory mice due to the lack of a functional Oas1b gene.
